GeoVax Labs Shares Outstanding 2006-2021 | GOVX

GeoVax Labs shares outstanding from 2006 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
GeoVax Labs Annual Shares Outstanding
(Millions of Shares)
2020 1
2019 0
2018 0
2017 69
2016 42
2015 32
2014 27
2013 21
2012 18
2011 16
2010 16
2009 15
2008 15
2007 714
2006 415
2005 313
GeoVax Labs Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 6
2021-03-31 5
2020-12-31 1
2020-09-30 1
2020-06-30 1
2020-03-31 0
2019-12-31 0
2019-09-30 0
2019-06-30 0
2019-03-31 0
2018-12-31 0
2018-09-30 0
2018-06-30 0
2018-03-31 0
2017-12-31 69
2017-09-30 67
2017-06-30 60
2017-03-31 55
2016-12-31 42
2016-09-30 44
2016-06-30 37
2016-03-31 35
2015-12-31 32
2015-09-30 32
2015-06-30 32
2015-03-31 32
2014-12-31 27
2014-09-30 25
2014-06-30 25
2014-03-31 25
2013-12-31 21
2013-09-30 22
2013-06-30 21
2013-03-31 20
2012-12-31 18
2012-09-30 18
2012-06-30 18
2012-03-31 17
2011-12-31 16
2011-09-30 16
2011-06-30 16
2011-03-31 16
2010-12-31 16
2010-09-30 16
2010-06-30 16
2010-03-31 16
2009-12-31 15
2009-09-30 15
2009-06-30 15
2009-03-31 15
2008-12-31 15
2008-09-30 744
2008-06-30 738
2008-03-31 732
2007-12-31 714
2007-09-30 713
2007-06-30 711
2007-03-31 713
2006-12-31 415
2006-09-30 317
2006-06-30 313
2006-03-31 313
2005-12-31 313
2005-09-30 313
2005-06-30 99
2005-03-31 99
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.027B $0.002B
GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29